Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
364 |
|
| Actual shortage: | 22 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 336 (92%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 1 (2%) | |
| Discontinued: | 55 (95%) | |
| Reversed: | 2 (3%) | |
Late reports |
27 (6%) |
|
Overdue reports |
12 (52%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRIAZOLAM | 0.25MG | TABLET | Resolved | 2017-04-28 | 2017-07-26 | 8423 |
| TRIAZOLAM | 0.25MG | TABLET | Resolved | 2018-03-26 | 2018-06-02 | 43911 |
| TRIAZOLAM | 0.25MG | TABLET | Resolved | 2019-06-05 | 2019-10-18 | 85664 |
| ROSIGLITAZONE | 2MG | TABLET | Resolved | 2017-07-26 | 2017-10-16 | 17325 |
| ROSIGLITAZONE | 4MG | TABLET | Resolved | 2017-08-24 | 2017-10-16 | 20214 |
| PINAVERIUM | 50MG | TABLET | Resolved | 2019-07-03 | 2019-08-31 | 88339 |
| PINAVERIUM | 50MG | TABLET | Resolved | 2020-09-22 | 2020-10-05 | 124792 |
| PINAVERIUM | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-20 | 142032 |
| PINAVERIUM | 50MG | TABLET | Resolved | 2023-11-01 | 2023-12-04 | 208864 |
| PINAVERIUM | 50MG | TABLET | Resolved | 2023-12-13 | 2024-02-08 | 213140 |
| PINAVERIUM | 100MG | TABLET | Resolved | 2019-08-07 | 2019-08-31 | 91100 |
| PINAVERIUM | 100MG | TABLET | Resolved | 2020-09-02 | 2020-10-05 | 123571 |
| PINAVERIUM | 100MG | TABLET | Resolved | 2021-01-29 | 2021-02-09 | 132735 |
| PINAVERIUM | 100MG | TABLET | Resolved | 2021-07-22 | 2021-08-20 | 142861 |
| PINAVERIUM | 100MG | TABLET | Resolved | 2023-11-01 | 2023-12-04 | 208859 |
| AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-29 | 2021-11-19 | 148545 |
| AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156999 |
| AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-14 | 2023-01-06 | 171833 |
| AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-02 | 2022-12-23 | 176948 |
| AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-13 | 2024-02-22 | 213143 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLOCTAFENINE | 200MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70194 |
| FLOCTAFENINE | 400MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70197 |
| SULFINPYRAZONE | 200MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70200 |
| TENOXICAM | 20MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70203 |
| TOLBUTAMIDE | 500MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70206 |
| TRIHEXYPHENIDYL | 2MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70209 |
| TRIHEXYPHENIDYL | 5MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70212 |
| CIMETIDINE | 300MG | TABLET | To be discontinued | 2019-01-02 | 2019-01-02 | 70796 |
| TICLOPIDINE | 250MG | TABLET | Discontinued | 2019-04-01 | 2019-04-02 | 80166 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| ISDN | 5MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108370 |
| ERYTHRO-S | 250MG | TABLET | Discontinued | 2020-07-28 | 2020-07-29 | 121300 |
| ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |
| ORAP | 2MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121834 |
| ORAP | 4MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121837 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |